Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review

  • ID: 4302709
  • SWOT Analysis
  • 49 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Laboratorios Grisi
  • Microbix Biosystems Inc
  • Nymox Pharmaceutical Corp
  • MORE
Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and animals and cosmeceutical and nutraceutical industries. The company’s portfolio include natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company along with its subsidiaries operates mainly in the US, Germany, China, Canada and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Ceapro Inc Key Recent Developments

May 17,2017: Ceapro Reports 2017 First Quarter Development Highlights and Financial Results
Apr 06,2017: Ceapro Reports 2016 Financial Results and Provides Corporate Update
Nov 23,2016: Ceapro Reports Third Quarter 2016 Financial and Operational Results
Sep 28,2016: Ceapro Announces the Grand Opening of New Bio-processing Extraction Facility
Sep 27,2016: Ceapro Awarded 2016 BioAlberta Achievement Award for Company of the Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Laboratorios Grisi
  • Microbix Biosystems Inc
  • Nymox Pharmaceutical Corp
  • MORE
Section 1 - About the Company
Ceapro Inc - Key Facts
Ceapro Inc - Key Employees
Ceapro Inc - Key Employee Biographies
Ceapro Inc - Major Products and Services
Ceapro Inc - History
Ceapro Inc - Company Statement
Ceapro Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Ceapro Inc - Business Description
Ceapro Inc - Corporate Strategy
Ceapro Inc - SWOT Analysis
SWOT Analysis - Overview
Ceapro Inc - Strengths
Ceapro Inc - Weaknesses
Ceapro Inc - Opportunities
Ceapro Inc - Threats
Ceapro Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Ceapro Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
May 17, 2017: Ceapro Reports 2017 First Quarter Development Highlights and Financial Results
Apr 06, 2017: Ceapro Reports 2016 Financial Results and Provides Corporate Update
Nov 23, 2016: Ceapro Reports Third Quarter 2016 Financial and Operational Results
Sep 21, 2016: Ceapro Awarded Research Grant from German-Canadian Centre for Innovation and Research
Sep 13, 2016: Ceapro Announces Allowance of Canadian Patent for Enabling Pressurized Gas eXpanded Technology
Aug 24, 2016: Ceapro Reports Second Quarter 2016 Financial and Operational Results
May 18, 2016: Ceapro Reports 2016 First Quarter Financial Results and Provides Corporate Update
May 09, 2016: Ceapro Presents Its PGX Technology at the 15th European Meeting on Supercritical Fluids
Apr 18, 2016: Ceapro Inc. Provides 2015 Business Highlights and 2016 Business Outlook
Apr 14, 2016: Ceapro Inc. Reports 2015 Financial Results, Best Financial Year in Company's History

Section 6 - Appendix
Methodology
Ratio Definitions

List of Tables
Ceapro Inc, Key Facts
Ceapro Inc, Key Employees
Ceapro Inc, Key Employee Biographies
Ceapro Inc, Major Products and Services
Ceapro Inc, History
Ceapro Inc, Subsidiaries
Ceapro Inc, Key Competitors
Ceapro Inc, Ratios based on current share price
Ceapro Inc, Annual Ratios
Ceapro Inc, Annual Ratios (Cont...1)
Ceapro Inc, Annual Ratios (Cont...2)
Ceapro Inc, Interim Ratios
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Ceapro Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Ceapro Inc, Performance Chart (2012 - 2016)
Ceapro Inc, Ratio Charts
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Nymox Pharmaceutical Corp
  • Microbix Biosystems Inc
  • Laboratorios Grisi
  • Generex Biotechnology Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll